Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains
- 1 June 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 307 (2) , 227-232
- https://doi.org/10.1016/0014-2999(96)00252-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Estrogen Alters MPTP‐Induced Neurotoxicity in Female Mice: Effects on Striatal Dopamine Concentrations and ReleaseJournal of Neurochemistry, 1996
- The vesicular monoamine transporter is not regulated by dopaminergic drug treatmentsEuropean Journal of Pharmacology, 1995
- Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase BNeuroscience Letters, 1994
- Differences in Nigral Neuron Number and Sensitivity to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 MiceExperimental Neurology, 1994
- Neural degeneration and the transport of neurotransmittersAnnals of Neurology, 1993
- MPTP neurotoxicity to cerebellar Purkinje cells in miceNeuroscience Letters, 1993
- Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatumBrain Research, 1989
- Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 miceEuropean Journal of Pharmacology, 1989
- MPTP Toxicity in Relation to Age, Dopamine Uptake and MAO‐B Activity in Two Rodent SpeciesBasic & Clinical Pharmacology & Toxicology, 1989
- Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicantNeuroscience Letters, 1988